Primary Intraocular Non-Hodgkin Lymphoma

hematologic malignancy

Identifier: CI-CAN-00003742
Entity page: /cancer/primary-intraocular-non-hodgkin-lymphoma ↗
Edges: 116

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Primary Intraocular Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 45show all (up to 200)
→ investigated in trials for	Rituximabmonoclonal antibody 14 trials (1 active) · roll-up of the cancer and its descendants	—	—	Primary Intraocular Non-Hodgkin Lymphoma	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabine

Primary Intraocular Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 71show all (up to 200)
→ studied in	NCT06973811Phase 2 · recruiting ZR-MTX for PIOL Phase II Trial · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07402876Phase 3 · recruiting A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Vitreoretinal Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07176130active not recruiting Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05841914recruiting Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01769222Phase 1 · terminated Ipilimumab and Local Radiation for Selected Solid Tumors · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Intraocular Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05950490unknown Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma · condition mapped ALIAS · 71 trials mapped (6 active)	—	—	Primary Vitreoretinal Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains